President John Dramani Mahama has officially commissioned two groundbreaking facilities at the Noguchi Memorial Institute for Medical Research: the Human Identification Laboratory, better known as the DNA Lab, and advanced mRNA and protein vaccine research laboratories.
Emphasizing the significance of the day, President Mahama noted, “Today we are commissioning two facilities with a shared purpose.This laboratory will help us provide families with answers in times of tragedy, and the vaccine research laboratories will also give our scientists the means to develop our own vaccines here in Ghana.”

He added that the endeavor marks a bold step to secure “a healthier, stronger, more self-reliant future for generations of Ghanaians to come” and affirms the nation’s determination to “safeguard its health security, advance scientific innovation, and chart its own course towards prosperity.”
”Referencing the August 6 tragedy that claimed the lives of eight gallant government and military officials, the President explained that the newly established DNA Laboratory eliminates the historical reliance on sending biological samples abroad, such as to South Africa, an experience that forced families of the deceased to wait nervously for days.
Reflecting on that delay, President Mahama declared, “It actually was a day of shame for Ghana that we couldn’t carry out our own DNA analysis in-country. That will be a thing of the past.”

He stressed that having a world-class facility will strengthen public health systems and “help us manage our affairs with competence, dignity, and independence.”
Furthermore, the lab will aid law enforcement in solving violent crimes like rape and murder, while also settling disputes regarding paternity, inheritance, and international travel
Because “behind every request for identification is a family that is waiting anxiously for news,” the President urged relevant agencies to communicate with grieving families with the utmost care and promptness.

Drawing critical lessons from the COVID-19 pandemic, when African nations were pushed to the back of the global supply queue and left dependent on external support, the President recalled how Western countries satisfied their domestic demands before passing on leftovers.
Lightly observing that Africa survived largely because “God is an African and he gave us the immunity not to die,” he warned that recurring infectious diseases like M-pox, Lassa fever, Ebola, and Marburg mean the nation must prepare before the next crisis strikes.
Through partnerships with the Africa CDC and local biomedical firms like Atlantic Life Sciences and DEK Laboratories, Ghana is now one of only five African countries utilizing cutting-edge mRNA technology

President Mahama also made a passionate call to Ghanaians to support and participate in clinical trials, urging the public to look past historical scaremongering about “guinea pigs” because “nobody would do the clinical trials for us to develop vaccines in our country.”
Highlighting international collaboration, he revealed that the National Vaccine Institute has initiated training programs for Ghanaian scientists locally and in Brussels, and is actively partnering with European institutions to explore advanced mRNA research, including cancer vaccines.

On his part the Minister for Health Kwabena Mintah Akandoh emphasized Ghana’s shift toward vaccine self-reliance and local scientific innovation.
He stated that Ghana’s first locally bottled vaccines are expected on the market in 2027 and outlined the government’s plans to sustain domestic medical research.
The Minister declared that “Ghana will not beg for vaccines. Ghana will make them,” stressing the country’s determination to move from external dependency to local production.
He noted that “the next pandemic will not wait. But neither will Ghana,” adding that the nation is ready to manufacture, regulate, and lead in health security.
Hon. Akandoh explained that the new. Vaccine Research Laboratories give Ghanaian scientists the tools to move locally from research and discovery to clinical trials and full vaccine production.

The Chief Executive of National Vaccine Institute (NVI) Dr. Sodzi Sodzi Tetteh emphasized that the facilities mark a historic milestone in building Ghana’s domestic scientific capacity, vaccine ecosystem, and health sovereignty.
Dr. Sodzi-Tettey noted that while it does not take a single day to build a previously non-existent vaccine ecosystem, sustained daily progress has enabled Ghana to join just four other African countries in deploying mRNA technology for vaccine research.
He therefore commended President Mahama for commitment to ensuring Ghana’s health Sovereignty and the Health Minister for his support in the realization of the facilities.
Source :www.senaradioonline.com































